<?xml version="1.0" encoding="UTF-8"?>
<ref id="B166-pharmaceuticals-12-00147">
 <label>166.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sharma</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tripathi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ranjan</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Garten</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Deyde</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Katz</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Lal</surname>
    <given-names>R.B.</given-names>
   </name>
   <name>
    <surname>Sambhara</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation</article-title>
  <source>PLoS ONE</source>
  <year>2011</year>
  <volume>6</volume>
  <elocation-id>e20215</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0020215</pub-id>
  <?supplied-pmid 21698289?>
  <pub-id pub-id-type="pmid">21698289</pub-id>
 </element-citation>
</ref>
